Cardiovascular Drugs Flashcards
Examples of acetylcholinesterase (ACE) inhibitors
Ramipril, Lisinopril, Quinapril
Examples of ARBs (angiotensin II receptor blockers)
Losartan
Valsartan
Eprosartan
Examples of CCBs (Calcium Channel Blockers) - rate limiting
Verapamil, Diltizem
Action of ACE inhibitors
Inhibits ACE conversion of angiotensin I to angiotensin II, therefore reducing BP due to Vasodilation (as angiotensin II is a vasoconstrictor and is inhibited)
Action of ARBS (angiotensin II receptor blockers)
Antagonise angiotensin II. Prevents vasoconstriction, aldosterone release and sympathetic activation. Results in BP reduction secondary to vasodilation
Action of CCBs (calcium channel blockers)
Vasodilators with balance of actions -> reducad heart rate. (These drugs have noticiable cardiac effects)
ACE inhibitors use
Combined with thiazide-like diuretics and CCBs as anti-hypertensive agents
Used in patients under 55
For heart failure
Left ventricular dysfunction
Post MI or congenital heart defects
Stroke prevention
ARBs use
Combined with thiazide-like diuretics and CCBs as anti-hypertensive agents
Patients under 55
Angiotensin-converting enzyme inhibitors (ACEIs) intolerance
Type 2 diabetic nephropathy (deterioration of kidney function)
CCBs use
Anti-hypertensives in combination with ACEIs/ARBs
Anti-arrhythmic: tachyarrhythmias such as AF
Post myocardial infarction
ACE inhibitors side effects
Dry irritant cough (due to accumulation of bradykinin)
Angioedema (swelling underneath he skin)
Hyperkalaemia (due to potassium retention, mediated by reduction of aldosterone)
Renal dysfunction
ARBs side effects
Hyperkalaemia due to potassium retention mediated by reduction of aldosterone
Impairment of renal function
Dizziness and syncope
CCBs side effects
Bradychardia and AV conduction delay
Constipation with verapamil
ACE inhibitors cautions
Renal dysfunction in patients with renal artery stenosis
Avoid in women with child bearing potential due to danger of foetal renal maldevelopment
ARBs cautions
Renal dysfunction in patients with artery stenosis
Avoid in women with child bearing potential due to danger of foetal renal maldevelopment
CCBs cautions
Negatively chronotropic and inotropic, so should be used with caution in combination with beta-blockers (Chronotropic factors are factors that affect the rate at which the cardiac muscle fibers contract. Inotropic factors are factors that affect the amount of force that the cardiac fibers contract)
Heart block and heart failure
Anti cholesterol drugs
Statins - anti lipid drugs
Fibrates
PCSK 9 inhibitors (for very high risk patients e.g inherited hyperlipopedia)
siRNA of PCSK9 (Inclisiran) - small interfering RNA that limits production of PCSK 9
Anti hypertensive drugs
Thiazide diuretics
Beta blockers
Vasodilators:
-calcium antagonists
-alpha 1 blockers
-ACE inhibits (ACEI)
-angiotensin receptor blockers (ARB)
Mineralocorticoid antagonist (spironolactone)
Alpha 2 or imidazoline receptor agonist (clonidine, moxonidine)
Statins
Anticholesterol
Example: simvastatin
Blocks HMG CoA redactase
Used in:
- hypercholesterolaemia
- diabetes
-angina/MI
-CVA/TIA
- high risk of MI and CVA
Side effects:
- myopathy
- rhabdomyolysis… renal failure
Fibrates
Anticholesterol
Example: bezafibrate
Used in:
- hypertriglyceridaemia
- low HDLcholesterol
PCSK 9 inhibitors
Anticholesterol
Examples: alirocumab, evolocumab
Used for: familial hypercholesterolaemia
Mechanism: inhibits the binding of PCSK9 to LDLR, PCSK9 inhibitor increases the number of LDLRs available to clear LDL, therefore lowering LDL-C levels
siRNA of PCSK9 (Inclisiran) - small interfering RNA that limits production of PCSK 9
Completely new class of drugs called gene silencing drugs
Mechanism: turns off/“silences” the gene PCSK9, boosting the livers ability to remove harmful cholesterol from the blood
Low blood pressure “numbers”
Systolic:<90mmHg
Diastolic:<60mmHh
Normal blood pressure “numbers”
Systolic: <140mmHg
Diastolic:<90mmHg
Current guidelines suggest:
Systolic:135mmHg or lower
Diastolic: 85mmHg or lower